Security key
800677106
SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share (SGMO)
CUSIP: 800677106
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, $0.01 par value per share
- Shares outstanding
- 414,359,662
- Total 13F shares
- 86,880,740
- Share change
- -13,740,902
- Total reported value
- $31,098,958
- Put/Call ratio
- 435%
- Price per share
- $0.36
- Number of holders
- 126
- Value change
- -$5,513,248
- Number of buys
- 55
- Number of sells
- 68
Report period
Q2 2024
Institutions
126
Top holders
10
SGMO full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
SANGAMO THERAPEUTICS, INC SEC filings
SANGAMO THERAPEUTICS, INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 800677106
Recent filing periods:
Top shareholders of SGMO - SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WASATCH ADVISORS LP |
13F
|
Company |
4.9%
|
20,132,324
|
$13,492,684 | — | 31 Mar 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
4.1%
|
16,958,477
|
$11,365,571 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.2%
|
13,277,637
|
$8,898,673 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.9%
|
12,200,368
|
$8,176,686 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.2%
|
4,943,260
|
$3,311,000 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.81%
|
3,363,791
|
$2,254,668 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.74%
|
3,067,435
|
$2,055,795 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.66%
|
2,751,804
|
$1,844,259 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.63%
|
2,597,977
|
$1,741,000 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.34%
|
1,428,255
|
$957,217 | — | 31 Mar 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.33%
|
1,373,500
|
$920,520 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.32%
|
1,322,548
|
$886,371 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.3%
|
1,242,131
|
$832,476 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.3%
|
1,228,885
|
$823,599 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.27%
|
1,104,877
|
$740,489 | — | 31 Mar 2024 | |
| Long Focus Capital Management, LLC |
13F
|
Company |
0.26%
|
1,098,000
|
$735,880 | — | 31 Mar 2024 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.19%
|
788,290
|
$489,000 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.18%
|
737,464
|
$494,248 | — | 31 Mar 2024 | |
| ZACKS INVESTMENT MANAGEMENT |
13F
|
Company |
0.17%
|
708,168
|
$474,601 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.15%
|
632,628
|
$423,987 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.13%
|
554,855
|
$371,864 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.13%
|
552,879
|
$370,539 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.13%
|
534,071
|
$357,934 | — | 31 Mar 2024 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.12%
|
493,431
|
$838,833 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.11%
|
473,111
|
$317,079 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.11%
|
445,300
|
$298,439 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.11%
|
436,655
|
$292,646 | — | 31 Mar 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.1%
|
400,000
|
$268,000 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.09%
|
368,743
|
$247,059 | — | 31 Mar 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.09%
|
364,284
|
$244,000 | — | 31 Mar 2024 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.09%
|
363,490
|
$243,611 | — | 31 Mar 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.08%
|
335,119
|
$224,530 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.07%
|
288,019
|
$193,030 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.07%
|
278,704
|
$187,000 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.06%
|
269,060
|
$180,270 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.06%
|
237,830
|
$159,394 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
222,300
|
$148,985 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.05%
|
222,055
|
$148,822 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.05%
|
218,826
|
$146,603 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.05%
|
191,949
|
$128,644 | — | 31 Mar 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.05%
|
191,792
|
$128,539 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.04%
|
160,300
|
$107,402 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
134,357
|
$90,046 | — | 31 Mar 2024 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.03%
|
124,902
|
$83,709 | — | 31 Mar 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.02%
|
94,236
|
$63,157 | — | 31 Mar 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.02%
|
81,142
|
$54,381 | — | 31 Mar 2024 | |
| MERITAGE PORTFOLIO MANAGEMENT |
13F
|
Company |
0.02%
|
78,260
|
$52,000 | — | 31 Mar 2024 | |
| State of Wyoming |
13F
|
Company |
0.02%
|
75,319
|
$50,479 | — | 31 Mar 2024 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.02%
|
73,421
|
$49,207 | — | 31 Mar 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.02%
|
72,160
|
$48,362 | — | 31 Mar 2024 |
Institutional Holders of SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share (SGMO) as of Q2 2024
As of 30 Jun 2024,
SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share (SGMO) was held by
126 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
86,880,740 shares.
The largest 10 holders included
WASATCH ADVISORS LP, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, BlackRock Inc., ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and GOLDMAN SACHS GROUP INC.
This page lists
126
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
125
Q2 2024 holders
126
Holder diff
1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.